Effect of Yogurt Added With Bifidobacteria and Soluble Fiber on Bowel Function.
Launched by INSTITUTO LALA · Jul 29, 2010
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
The use of probiotics and prebiotics has become popular in human nutrition and food product development. The most common probiotics are Lactobacillus and Bifidobacterium species. Bifidobacteria spp are dominant in the intestinal microflora and are considered to be beneficial to the host, for this reason research efforts have focused on increasing their proportion in the intestinal microflora through oral administration of mixtures containing bifidobacteria or oral supplementation with prebiotics. An important limitation for the effectiveness of oral probiotics is that they might be destroye...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 18 and 55 years,
- • be free of known gastrointestinal diseases,
- • desist of consuming prebiotic and/or probiotic-containing foods or dietary supplements during the entire duration of the study,
- • agree to avoid any medication that produced changes in gastrointestinal function, diarrhea or constipation until completion of the study,
- • be willing to complete all necessary study questionnaires,
- • accept voluntary participation and sign a written informed consent before inclusion in the study.
- Exclusion Criteria:
- • subjects receiving any kind of treatment that may had altered bowel function;
- • intake of laxatives,
- • a concomitant sever gastrointestinal disease;
- • that were consuming probiotics and/or prebiotics-containing foods or dietary supplements within the two previous weeks;
- • subjects were also excluded if they had received any antimicrobial medication during the previous 2 months.
About Instituto Lala
Instituto Lala is a leading clinical research organization dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a strong emphasis on ethical practices and scientific rigor, Instituto Lala collaborates with healthcare professionals and institutions to develop and evaluate new therapeutic approaches across various medical fields. Committed to improving patient outcomes, the institute leverages cutting-edge methodologies and a team of experienced researchers to contribute to the global body of medical knowledge and enhance the quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Queretaro, , Mexico
Patients applied
Trial Officials
Jorge JL Rosado, PhD
Principal Investigator
UAQ
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials